IMU 0.00% 2.0¢ imugene limited

News: Imugene therapy targets cancer at Melbourne, Sydney Luncheons

  1. The “new” Imugene is involved in one of the hottest areas of cancer study and appears lightly valued V global peers in Immuno-Oncology...immunotherapy has become one of the most promising areas of study for the treatment of a variety of cancerous tumour. Charles Walker will present the new Imugene at the Melbourne (Tues 10th Feb) / Sydney Investor Luncheons (Wed 11th Feb).

watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Mkt cap $72.19M
Open High Low Value Volume
2.1¢ 2.1¢ 2.0¢ $16.96K 837.5K

Buyers (Bids)

No. Vol. Price($)
16 8525656 2.0¢

Sellers (Offers)

Price($) Vol. No.
2.1¢ 1045183 9
Last update - 16.10pm 18/01/2019 (20 minute delay) ?
0.00 ( 0.00 %)
Open High   Low Volume
2.1¢ 2.1¢   2.0¢ 575370
Last updated 15.59pm 18/01/2019 (live) ?
IMU (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.